Mizuho Downgrades Chemours Co to Neutral; Top 5 Analyst Downgrades for Wednesday

Mizuho analyst John Roberts downgraded Chemours Co from Outperform to Neutral, lowering its price target. The report lists five major analyst downgrades for Wednesday, including Chemours, Contineum Therapeutics, Albertsons, Bruker, and Safehold.